Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice

Secondary bacterial pneumonia is a frequent complication of influenza, associated with high morbidity and mortality. We hypothesized that treatment with neutralizing influenza A antibody AT10_002 protects against severe secondary pneumococcal infection in a mouse model of influenza A infection. Infl...

Descripción completa

Detalles Bibliográficos
Autores principales: van Someren Gréve, Frank, van der Sluijs, Koenraad F., Tuip, Anita M., Schultz, Marcus J., de Jong, Menno D., Juffermans, Nicole P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055667/
https://www.ncbi.nlm.nih.gov/pubmed/29718555
http://dx.doi.org/10.1002/jmv.25212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055667/
https://www.ncbi.nlm.nih.gov/pubmed/29718555
http://dx.doi.org/10.1002/jmv.25212

Ejemplares similares